Skip to content Skip to navigation
University of Warwick
  • Study
  • |
  • Research
  • |
  • Business
  • |
  • Alumni
  • |
  • News
  • |
  • About

University of Warwick
Publications service & WRAP

Highlight your research

  • WRAP
    • Home
    • Search WRAP
    • Browse by Warwick Author
    • Browse WRAP by Year
    • Browse WRAP by Subject
    • Browse WRAP by Department
    • Browse WRAP by Funder
    • Browse Theses by Department
  • Publications Service
    • Home
    • Search Publications Service
    • Browse by Warwick Author
    • Browse Publications service by Year
    • Browse Publications service by Subject
    • Browse Publications service by Department
    • Browse Publications service by Funder
  • Statistics
  • Help & Advice
University of Warwick

The Library

  • Login

A coupled drug kinetics-cell cycle model to analyse the response of human cells to intervention by topotecan

Tools
- Tools
+ Tools

Chappell, M. J. (Michael J.), Evans, N. D., Errington, Rachel J., Khan, I. A., Campbell, L., Ali, Reza, Godfrey, Keith and Smith, Paul J. (Paul James), 1953-. (2008) A coupled drug kinetics-cell cycle model to analyse the response of human cells to intervention by topotecan. Computer Methods and Programs in Biomedicine, Vol.89 (No.2). pp. 169-178. ISSN 0169-2607

[img]
Preview
PDF
WRAP_Chappell_0873262-es-060312-cmpbpaperrev.pdf - Submitted Version - Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader

Download (1032Kb)
Official URL: http://dx.doi.org/10.1016/j.cmpb.2007.11.002

Abstract

A model describing the response of the growth of single human cells in the absence and presence of the anti-cancer agent topotecan (TPT) is presented. The model includes a novel coupling of both the kinetics of TPT and cell cycle responses to the agent. By linking the models in this way, rather than using separate (disjoint) approaches, it is possible to illustrate how the drug perturbs the cell cycle. The model is compared to experimental in vitro cell cycle response data (comprising single cell descriptors for molecular and behavioural events), showing good qualitative agreement for a range of TPT dose levels.

Item Type: Journal Article
Subjects: R Medicine > RC Internal medicine > RC0254 Neoplasms. Tumors. Oncology (including Cancer)
R Medicine > RM Therapeutics. Pharmacology
T Technology > TA Engineering (General). Civil engineering (General)
Divisions: Faculty of Science > Engineering
Library of Congress Subject Headings (LCSH): Pharmacokinetics -- Mathematical models, Cell cycle -- Mathematical models, Cancer cells, Cancer -- Treatment
Journal or Publication Title: Computer Methods and Programs in Biomedicine
Publisher: Elsevier Ireland Ltd.
ISSN: 0169-2607
Date: February 2008
Volume: Vol.89
Number: No.2
Number of Pages: 10
Page Range: pp. 169-178
Identification Number: 10.1016/j.cmpb.2007.11.002
Status: Peer Reviewed
Publication Status: Published
Access rights to Published version: Restricted or Subscription Access
Funder: Biotechnology and Biological Sciences Research Council (Great Britain) (BBSRC)
Grant number: 88/E19305 (BBSRC)
Title of Event: Workshop on Nordic Models of Capitalism
Location of Event: Univ Birmingham, Birmingham, ENGLAND
Date(s) of Event: OCT 08-09, 2004
References: [1] Errington, R. J., S. M. Ameer-Beg, B. Vojaovic, L. H. Patterson, M. Zloh and P. J. Smith. Advanced microscopy solutions for monitoring the kinetics and dynamics of drug-DNA damage-activated G2 checkpoint. Adv. Drug Deliv. Rev., 57, (2003), 153–167. [2] Tyson, J. J. and B. Novak. Regulation of the eukaryotic cell cycle: molecular antagonism, hysteresis and irreversible transitions. J.Theor. Biol., 210, (2001), 249–263. [3] Alarcón, T., H. M. Byrne and P. K. Maini. A mathematical model of the effects of hypoxia on the cell cycle of normal and cancer cells. J. Theor. Biol., 229, (2004), 395–411. [4] Thomas N, Kenrick M, Giesler T, Kiser G, Tinkler H, Stubbs S. Characterization and gene expression profiling of a stable cell line expressing a cell cycle GFP sensor. Cell Cycle, 4(1), (2005), 191-5. [5] Thomas N. Lighting the circle of life: fluorescent sensors for covert surveillance of the cell cycle. Cell Cycle, 2(6), (2003), 545-9. [6] Bailly, C. Topoisomerase-I poisons and suppressors as anti-cancer drugs. Curr. Med. Chem., 7, (2000), 39–58. [7] Wang, J. C.. DNA topoisomerases. Annu.Rev. Biochem., 65, (1996), 635–692. [8] Thomas, N. and I. D. Goodyear. Stealth sensors: real-time monitoring of the cell cycle. Targets, 2, (2003), 26–33. [9] Feeney, G. P., R. J. Errington, M. Wiltshire, N. Marquez, S. C. Chappell and P. J. Smith. Tracking the cell cycle origins for escape from topotecan action by breast cancer cells. Br. J. Cancer, 88, (2003), 1310–1317. [10] Lakowicz, J. R., I. D. Fang, Z. Gryczynski, I. Gryczynski and T. G. Burke. Fluorescence spectral properties of the anti- cancer drug topotecan by steady-state and frequency domain fluorometry with one- photon and multi-photon excitation. Photochemistry & Photobiology, 69, (1999), 421–428. [11] Evans, N. D., R. J. Errington, M. J. Chapman, P. J. Smith, M. J. Chappell and K. R. Godfrey. Compartmental modelling of the uptake kinetics of the anti-cancer agent topotecan in human breast cancer cells. Int. J. Adapt. Control Signal Process., 19, (2005), 395– 417. [12] Khan, I. A., J. Fisher, P. J. Smith and R. J. Errington. A Bioinformatics approach for the interrogation of molecular events in single cells: transforming fluorescent timelapse microscopy images into numbers. BMC Systems Biology (2007) (in press). [13] AEA Technology, Facsimile (Unix version) User Guide. Harwell Laboratory: Didcot, Oxfordshire, UK, 1994.
URI: http://wrap.warwick.ac.uk/id/eprint/30637

Data sourced from Thomson Reuters' Web of Knowledge

Request changes to a record

Actions (login required)

View Item View Item

Document Downloads

More statistics for this item...
twitter

Email us: publications@warwick.ac.uk
Contact Details
About Us